Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05718297
Title Brigatinib Post Definitive Chemo-radiotherapy in Patients With ALK-fusion Non-small Cell Lung Cancer (BOUNCE)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors ETOP IBCSG Partners Foundation
Age Groups: adult | senior
Covered Countries ITA | GBR | FRA | ESP

Facility Status City State Zip Country Details
CHU Angers Angers France Details
Caen - CHU Caen France Details
Hôpital de Marseille Marseille France Details
IRCCS Instituto Tumori Giovanni Paolo II Bari Italy Details
IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola Italy Details
AOU Maggiore della Carità Novara Italy Details
Fondazione IRCCS Policlinico S. Matteo Pavia Italy Details
Santa Maria della Misericordia Hospital Perugia Italy Details
AULSS2 Marca Trevigiana Treviso Treviso Italy Details
Universita di Verona - Department of Medicine Verona Italy Details
Medical University Gdansk Gdańsk Poland Details
Hospital Universitario Dr Balmis Alicante - ISABIAL Alicante Spain Details
Hospital de la Santa Creu i Sant Pau Barcelona Spain Details
Hospital Vall d'Hebron Barcelona Spain Details
Hospital Universitario Basurto Bilbao Spain Details
Hospital Universitario de Jerez de la Frontera Jerez De La Frontera Spain Details
Hospital Universitario Lucus Augusti Lugo Spain Details
H. Puerta de Hierro Majadahonda Majadahonda Spain Details
Royal Marsden Hospital (Fulham Road) London United Kingdom Details
Royal Marsden Hospital (Sutton) London United Kingdom Details
*Shaded cells indicate that there was no data available from for the field